Parathyroid Tumor Clonal Status

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Washington University School of Medicine
Study ID
NCT05997810
Status
Recruiting
Apply to this trial

Conditions

  • Parathyroid Tumor
  • Primary Hyperparathyroidism
  • Secondary Hyperparathyroidism (SHPT)
  • Tertiary Hyperparathyroidism

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 80 Years
Healthy Volunteers
Accepted

Study Details

To define the frequency of monoclonal-X and polyclonal-X tumors in hyperparathyroid disorders patients having PTX and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).

Key Dates

Start date
Jul 28, 2023
Status verified
May 2026
Primary completion
Jan 31, 2031
Completion
Jan 31, 2032

Study Design

Enrollment
839 participants (estimated)

Primary Outcome Measure

Primary Endpoint 1 [ Time Frame: 24 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University School of MedicineSt LouisMissouri63110
Bryan Bear
[email protected]
314-651-9717

Find similar trials in St Louis, MO

By research site
Washington University School of Medicine· St Louis, MO

Related Studies